AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Healtinib 12.5mg Capsule

Prescription Icon
Prescription Required

Marketer

Torrent Pharmaceuticals Ltd

Salt Composition

Sunitinib (12.5mg)

Overview Healtinib 12.5mg Capsule

Oncaspar 12.5mg capsules are indicated for treating kidney cancer and gastrointestinal stromal tumors. This medication inhibits specific enzymes crucial for cancer cell proliferation, thereby reducing tumor size and slowing disease progression. Oncaspar 12.5mg capsules may be administered with or without food, but consistent daily timing optimizes therapeutic effects. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. While benefits may not be apparent for weeks or months, discontinue use only under medical supervision. Common side effects include fatigue, diarrhea, nausea, vomiting, altered taste perception, and reduced appetite. Regular monitoring of blood pressure and thyroid function is often recommended, as this medication can lower blood sugar levels potentially causing fainting. Diabetics must monitor blood glucose closely and adjust anti-diabetic medication as directed by their physician. Inform your doctor of any pre-existing heart, liver, kidney, or bleeding disorders before commencing treatment. Due to potential drug interactions, disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding; effective contraception is essential for both partners throughout treatment.

Primary Ingredients of Healtinib 12.5mg Capsule

No text was provided to rewrite.

Uses of Healtinib 12.5mg Capsule

Managing Renal Cell Carcinoma and Gastrointestinal Stromal Tumors

Major Benefits of Healtinib 12.5mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Healtinib 12.5mg Capsules. These capsules can be ingested with or without food, however, consistent daily timing is recommended.

Common Side effects of Healtinib 12.5mg Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Healtinib 12.5mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Healtinib 12.5mg Capsules. These capsules can be ingested with or without food, though consistent timing is recommended.

How Healtinib 12.5mg Capsule works:

Oncasin 12.5mg capsules are an anti-neoplastic agent. Their mechanism involves targeted inhibition of tyrosine kinase receptors on cancer cells, thus halting their replication. Simultaneously, the drug limits angiogenesis within the tumor, further suppressing malignant cell expansion.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Healtinib 12.5mg Capsules is not considered safe without medical guidance. Seek your physician's advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Healtinib 12.5mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Healtinib 12.5mg capsules while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Healtinib 12.5mg Capsules might lead to adverse reactions that impair driving ability. Dizziness is a possible side effect of this medication. Refrain from driving or operating machinery if dizziness occurs during treatment.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney impairment may safely take Healtinib 12.5mg capsules without requiring a dosage modification.

LiverLiverSAFE IF PRESCRIBED

For patients with hepatic impairment, Healtinib 12.5mg capsules may be administered without dosage modification. The 12.5mg capsule formulation of Healtinib is considered safe in this population.

What if you forget to take Healtinib 12.5mg Capsule :

Omit any missed Healtinib 12.5mg Capsule dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Healtinib 12.5mg Capsule

LabelValue
Chemical Category Indole and Pyrrole Derivatives
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Healtinib 12.5mg Capsule

Follow your doctor's instructions precisely when taking Healtinib 12.5mg Capsules. Only doctors experienced with cancer medications should prescribe this drug. Take one capsule daily, with or without food. Avoid grapefruit juice and grapefruit while using Healtinib 12.5mg Capsules to minimize the risk of side effects.
Healtinib 12.5mg Capsule may cause skin lightening and hair loss. You might also experience dryness, thickening, cracking, blistering, or rashes on your palms and soles. While these side effects usually disappear after treatment ends, serious, potentially fatal skin reactions like severe rash or rapidly spreading skin ulceration are possible. Report any skin injury accompanied by infection symptoms (fever, pain, redness, swelling, pus, or blood drainage) to your doctor immediately.
Healtinib 12.5mg Capsules can cause life-threatening liver damage. Report itching, yellowing of eyes or skin, dark urine, or right upper stomach pain immediately to your doctor. Your doctor will monitor your liver function with blood tests before and throughout treatment. Treatment may be temporarily or permanently stopped if liver problems develop.
Healtinib 12.5mg Capsules have no generic equivalents. They work by inhibiting protein kinase, an enzyme on cancer cells that fuels their growth and spread. This action prevents cancer progression. Other protein kinase inhibitors include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
Healtinib 12.5mg Capsules haven't been studied with other chemotherapy drugs. Its use in gastrointestinal stromal tumors (GIST), a cancer affecting the stomach and intestines, is specifically for patients whose imatinib treatment has failed or is unsuitable.
Healtinib 12.5mg Capsules can lower blood sugar. Diabetics should monitor their blood sugar closely as it may drop dangerously low, potentially causing unconsciousness. Your anti-diabetic medication dosage may require adjustment based on these blood sugar readings.
Healtinib 12.5mg Capsules may raise blood pressure. Regular blood pressure monitoring is essential. Report severe headache, dizziness, lightheadedness, or vision changes to your doctor immediately. They may adjust your medication or temporarily suspend treatment until your blood pressure normalizes.
Healtinib 12.5mg Capsule
397
MRP 460
13% off